Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study - Iwata, Yusuke; Nakajima, Shinichiro; Plitman, Eric; Caravaggio, Fernando; Kim, Julia; Shah, Parita; Mar, Wanna; Chavez, Sofia; De Luca, Vincenzo; Mimura, Masaru; Remington, Gary; Gerretsen, Philip; et al. (Biological psychiatry (1969), 2019)
Keywords: 1H-MRS; Adult; Antipsychotic; Antipsychotic Agents - pharmacology; Caudate Nucleus - diagnostic imaging; Caudate Nucleus - metabolism; Clozapine; Cross-Sectional Studies; Female; Glutamate; Glutamic Acid - metabolism; Glutamine - metabolism; Gyrus Cinguli - diagnostic imaging; Gyrus Cinguli - metabolism; Humans; Male; Middle Aged; Prefrontal Cortex - diagnostic imaging; Prefrontal Cortex - metabolism; Proton Magnetic Resonance Spectroscopy; Psychiatric/Mental Health; Schizophrenia; Schizophrenia - diagnostic imaging; Schizophrenia - drug therapy; Schizophrenia - metabolism; Treatment-resistant; Treatment-resistant; Schizophrenia; 1H-MRS; Antipsychotic; Clozapine; Glutamate; H-MRS